Brugada Criteria for Ventricular Tachycardia
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- VT1–1
- SVT with Aberrancy0–0
The Brugada Criteria for Ventricular Tachycardia calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include absence rs precordial. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Distinguishes ventricular tachycardia from supraventricular tachycardia with aberrancy using ECG morphology criteria
Clinical Indication
The Brugada Criteria for Ventricular Tachycardia is indicated for bedside clinical practice to support Distinguishes ventricular tachycardia from supraventricular tachycardia with aberrancy using ECG morphology criteria. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines. Guideline pearl: Original study reported 98.7% sensitivity and 96.5% specificity for VT detection.
Sequential algorithm: Step 1: Absence of RS in V1-V6? Step 2: R-S interval >100ms? Step 3: AV dissociation? Step 4: Morphology criteria for VT? Any 'yes' = VT diagnosis
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| absence_rs_precordial | string | Yes | Absence of RS complex in all precordial leads (V1-V6) |
| r_to_s_interval_100ms | string | Yes | R to S interval >100 ms in any precordial lead |
| av_dissociation | string | Yes | Atrioventricular dissociation present |
| morphology_criteria_vt | string | Yes | Morphology criteria for VT present in V1-V2 and V6 |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 1–1 | VT | Ventricular Tachycardia |
| 0–0 | SVT with Aberrancy | Supraventricular Tachycardia with Aberrancy |
Evidence-Based References (EBM)
- Brugada P, Brugada J, Mont L, Smeets J, Andries EW. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation. 1991;83(5):1649-59. doi: 10.1161/01.cir.83.5.1649.DOI: 10.1161/01.cir.83.5.1649
- Isenhour JL, Craig S, Gibbs M, Littmann L, Rose G, Risch R. Wide-complex tachycardia: continued evaluation of diagnostic criteria. Acad Emerg Med. 2000;7(7):769-73. doi: 10.1111/j.1553-2712.2000.tb02267.x.DOI: 10.1111/j.1553-2712.2000.tb02267.x
- Vereckei A, Duray G, Szénási G, Altemose GT, Miller JM. Application of a new algorithm in the differential diagnosis of wide QRS complex tachycardia. Eur Heart J. 2007;28(5):589-600. doi: 10.1093/eurheartj/ehl473.DOI: 10.1093/eurheartj/ehl473